Fatty acids, gene expression, and coronary heart disease (CHD)

Nutrigenomics

Volumn , Issue , 2005, Pages 181-200

  Minihane, Anne M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68049096748     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (65)

1. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr 2001; 131:1129-1132.
2. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999; 19:63-90.
3. Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem 2000; 40:30749-30752.
4. Sessler AM, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. J Nutr 1998; 128:923-926.
5. Wahle KWJ, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nut Soc 2003; 62:349-360.
6. 13C a-linolenic acid to longer-chain fatty acids and partitioning towards ^-oxidation. Br J Nutr 2003; 90:311-321.
7. MAFF (Ministry of Agriculture Fisheries and Food) Food Information. Surveillance Sheet 127. Dietary intake of iodine and fatty acids. London: MAFF, 1997a.
8. Frayn KN. Lipoprotein metabolism. In: Frayn KN, ed. Metabolic Regulation: A Human Perspective. 2nd ed. Oxford, UK: Blackwell Science, 2003:253-280.
9. Berk PD, Stump DD. Mechanism of cellular uptake of long chain free fatty acids. Mol Cell Biochem 1999; 192:17-31.
10. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273:16710-16714.
11. Allmann DW, Gibson DW. Fatty acid synthesis during early linoleic acid deficiency in the mouse. J Lipid Res 1969; 6:51-62.
12. Wahle KWJ, Radcligge JD. Effects of a diet rich in sunflower oil on aspects of lipid metabolism in genetically obese rats. Lipids 1977; 12:109-115.
13. Cho HP, Nakamura MT, Clarke SD. Cloning expression and nutritional regulation of the human delta-6 desaturase. J Biol Chem 1999a; 274:471-477.
14. Cho HP, Nakamura MT, Clarke SD. Cloning, expression and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999b; 274:37335-37339.
15. Forest C, Franckhauser S, Glorian M, Antras-Ferry J, Robin D, Robin P. Regulation of gene transcription by fatty acids, fibrates and prostaglandins: the phosphoenolpyru-vate carboxykinase gene as a model. Prostaglandins Leukot Essent Fatty Acids 1997; 57:47-56.
16. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347:709-710.
17. Jump DB, Clarke SD, MacDougald O, Thelen A. Polyunsaturated fatty acid inhibits S14 gene transcription in liver and cultured hepatocytes. Proc Natl Acad Sci USA 1993; 90:8454-8458.
18. Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem 2000; 275:30749-30752.
19. Couet C, Delarue J, Fitz P, Antonine JM, Lamisse F. Effects of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int Obes J 1997; 21:637-643.
20. Power GW, Newsholme EA. Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase in I rat heart and skeletal muscle. J Nutr 1997; 127:2142-2150.
21. Karara A, Dishman E, Blair I, Falck JR, Capdevila JH. Endogenous epoxyeicosatrie-noic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J Biol Chem 1989; 264:19822-19827.
22. Nakamura MT, Cho HP, Clarke SD. Regulation of delta-6 desaturase expression and its role in the polyunsaturated fatty acid inhibition of fatty acid synthase gene expression in mice. J Nutr 2000; 130:1561-1565.
23. Clarke SD. Polyunsaturated fatty acid regulation of gene expression: a mechanism to improve energy balance and insulin resistance. Br J Nutr 2000; 83:S59-S66.
24. Mori TA, Bao DQ, Burke V, Pudey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999; 70:817-825.
25. Lowell BB. PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 1999; 99:239-242.
26. Morrison RF, Farmer SR. Hormonal signalling and transcriptional control of adipocyte differentiation. J Nutr 2000; 130:3116S-3121S.
27. Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr 2000; 130:3122S-3126S.
28. Berger J, Moller DE. The mechanism of action of PPAR. Annu Rev Med 2002; 53:409-435.
29. Beisiegel U, Heeren J, Schnieders F. Fatty acids and gene expression. In: Zempleni J, Daniel H, eds. Molecular Nutrition. Wallingford, UK: CABI Publishing, 2003:167-186.
30. Brun RP, Kim JB, Hu E, Spiegelman BM. Peroxisome proliferator-activated receptor g and the control of adipogenesis. Curr Opin Lipidol 1997; 8:212-218.
31. Rangwala SM, Lazar MA. Transcriptional control of adipogenesis. Annu Rev Nutr 2000; 20:535-559.
32. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270:12953-12956.
33. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet Med 1999; 16:179-192.
34. Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARy in the control of lipid metabolism. J Lipid Res 2002; 43:177-186.
35. Tartaglia TA. The leptin receptor. J Biol Chem 1997; 272:6093-6096.
36. Reseland JE, Anderssen SA, Solvoll K, Hjerman I, Urdal P, Holme I, Drevon CA. Effect of long term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001a; 73:240-245.
37. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen ER, Drevon CA. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001b; 42:743-750.
38. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001; 11:93-102.
39. Calder PC. N-3 polyunsaturated fatty acids and cytokine production in health and disease. Annu Nutr Metab 1997; 41:203-234.
40. Wahle KWJ, Rotondo D. Fatty acids and endothelial cell function: regulation of adhesion molecule and redox enzyme expression. Curr Opin Clin Nutr Metab Care 1999; 2:109-115.
41. Farquharson A, Wu H-C, Grant I, Choung J-J, Eremin O, Heys SD, Wahle KWJ. Possible mechanisms for the putative anti-atherogenic and anti-tumorigenic effects of conjugated polyenoic fatty acids. Lipids 1999; 34:S343.
42. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996; 31:S57-S63.
43. Collie Duguid ESR, Wahle KWJ. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996; 220:269-274.
44. Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, Calder PC. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci 2001; 100:91-100.
45. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000; 19:427S-477S.
46. Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. Peroxisome proliferator activated receptor-a expression in human liver. Mol Pharmacol 1998; 53:14-22.
47. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294:1866-1870.
48. Kersten S, Desvergne B, Wahli W. Role of PPAR’s in health and disease. Nature 2000; 405:421-424.
49. Hihi AK, Michalik L, Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol Life Sci 2002; 59:790-798.
50. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Rev 1999; 20:649-688.
51. Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 2002; 64:893-901.
52. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferators-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37:907-925.
53. Henry RR. Thiazolidinediones. Endocrinol Metab Clin North Am 1997; 26:553-573.
54. Auwerx J. Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferators activated receptors. The Belgian Endocrine Society Lecture, 1992. Human Res 1992; 38:269-277.
55. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble KS, Devachand P, Wahli W, Wilson TM, Lenhar J, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferators-activated receptor a (PPARa). J Biol Chem 1997; 278:5678-5684.
56. Krey G, Braissant O, L’Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W. Fatty acids, eicosanoids and hypolipidaemic agents identified as ligands of perixo-some proliferators-activated receptors by coactivation dependent receptor ligand assay. Mol Endocrinol 1997; 11:779-791.
57. Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha. J Lipid Res 1999; 40:1426-1433.
58. Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells and blood. Proc Natl Acad Sci USA 1999; 96:1041-1048.
59. Xu J, Nakamura MT, Cho HP, Clarke SD. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. J Biol Chem 1999; 274:23577-23583.
60. Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear receptor-4a. Nature 1998; 392:512-516.
61. Jiang G, Nepomuceno L, Hopkins K, Sladek FM. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol 1995; 15:5131-5143.
62. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, Chiarpotto E, Baeerle PA, Poli G. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996; 229:643-647.
63. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997; 41:203-234.
64. Austin MA, King MC, Vranigan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990; 82:495-506.
65. Minihane AM, Brady LM, Lovegrove SS, Lesauvage SV, Williams CM, Lovegrove JA. Lack of effect of dietary n-6:n-3 ratio PUFA on plasma lipids and markers of insulin responses in Indian Asians. Eur J Nutr 2005; 44:26-32.